Cargando…
A rare compound heterozygous EIF2AK4 mutation in pulmonary veno-occlusive disease
BACKGROUND: Pulmonary veno-occlusive disease (PVOD) is a rare, progressive, and oft-fatal condition of pulmonary arterial hypertension that is typically difficult to diagnose and treat. However, with the development of next-generation sequencing technology, an increasing number of patients with PVOD...
Autores principales: | Zhang, Chun, Du, Qiang, Wang, Sha, Zhang, Ruifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710057/ https://www.ncbi.nlm.nih.gov/pubmed/36451176 http://dx.doi.org/10.1186/s12890-022-02256-9 |
Ejemplares similares
-
EIF2AK4 mutation in pulmonary veno-occlusive disease: A case report and review of the literature
por: Liang, Li, et al.
Publicado: (2016) -
Differential Diagnosis of Pulmonary Veno-Occlusive Disease and/or Pulmonary Capillary Hemangiomatosis after Identification of Two Novel EIF2AK4 Variants by Whole-Exome Sequencing
por: Park, Jong Eun, et al.
Publicado: (2023) -
Identification of Two Novel Compound Heterozygous EIF2AK3 Mutations Underlying Wolcott–Rallison Syndrome in a Chinese Family
por: Zhao, Na, et al.
Publicado: (2021) -
Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation
por: Liang, Li, et al.
Publicado: (2018) -
EIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension
por: Eichstaedt, Christina A., et al.
Publicado: (2016)